Previous Close | 12.40 |
Open | 12.40 |
Bid | 11.90 x 0 |
Ask | 12.30 x 0 |
Day's Range | 12.40 - 12.40 |
52 Week Range | 8.90 - 19.30 |
Volume | |
Avg. Volume | 0 |
Market Cap | 452.953M |
Beta (5Y Monthly) | 1.05 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
Orthofix's (OFIX) fourth-quarter earnings and revenues beat their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
Orthofix Medical Inc (OFIX) released its 8-K filing on March 5, 2024, showcasing a year of substantial growth and operational efficiency